ETS transcription factors in the tumor microenvironment

Open Cancer Journal

Volumn 3, Issue SPEC. ISSUE 1, 2010, Pages 49-54

  Li, Fu ^a,b   Wallace, Julie A ^a,b   Ostrowski, Michael C ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; ETS factors; Tumor microenvironment

Indexed keywords

COLLAGEN TYPE 4; FIBROBLAST GROWTH FACTOR; GELATINASE B; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL XL; RAS PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR ELF 1; TRANSCRIPTION FACTOR ELK 4; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR PU 1; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER GROWTH; CELL ADHESION; CELL CYCLE REGULATION; CELL GROWTH; CELL MIGRATION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; LIMB DEVELOPMENT; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION REGULATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 78249254273     PISSN: None     EISSN: 18740790     Source Type: Journal    
DOI: 10.2174/1874079001003010049     Document Type: Article

References (47)

1. Beug H, von Kirchbach A, Doderlein G, Conscience JF, Graf T. Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 1979; 18: 375-390.
2. Leprince D, Gegonne A, Coll J, et al. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 1983; 306: 395-397.
3. Gutierrez-Hartmann A, Duval DL, Bradford AP. ETS transcrip-tion factors in endocrine systems. Trends Endocrinol Metab 2007; 18: 150-158.
4. Seth A, Watson DK, Blair DG, Papas TS. c-ets-2 protooncogene has mitogenic and oncogenic activity. Proc Natl Acad Sci USA 1989; 86: 7833-7837.
5. Seth A, Watson DK. ETS transcription factors and their emergingroles in human cancer. Eur J Cancer 2005; 41: 2462-2478.
6. Clark JP, Cooper CS. ETS gene fusions in prostate cancer. Nat RevUrol 2009; 6: 429-39.
7. Hsu T, Trojanowska M, Watson DK. ETS proteins in biologicalcontrol and cancer. J Cell Biochem 2004; 91: 896-903.
8. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
9. Powers S, Mu D. Genetic similarities between organogenesis and tumorigenesis of the lung. Cell Cycle 2008; 7: 200-2004.
10. Zhang Z, Verheyden JM, Hassell JA, Sun X. FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds. Dev Cell 2009; 16: 607-613.
11. Mao J, McGlinn E, Huang P, Tabin CJ, McMahon AP. Fgf- dependent Etv4/5 activity is required for posterior restriction of Sonic Hedgehog and promoting outgrowth of the vertebrate limb. Dev Cell 2009; 16: 600-606.
12. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 2000; 50: 1-15.
13. Dejana E, Taddei A, Randi AM. Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta 2007; 1775: 298-312.
14. De Val S, Black BL. Transcriptional control of endothelial cell development. Dev Cell 2009; 16: 180-195.
15. Liu F, Patient R. Genome-wide analysis of the zebrafish ETS family identifies three genes required for hemangioblast differentiation or angiogenesis. Circ Res 2008; 103: 1147-1154.
16. Pham VN, Lawson ND, Mugford JW, et al. Combinatorial function of ETS transcription factors in the developing vasculature. Dev Biol 2007; 303: 772-783.
17. Lee D, Park C, Lee H, et al. ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell 2008; 2: 497-507.
18. Sumanas S, Gomez G, Zhao Y, Park C, Choi K, Lin S. Interplay among Etsrp/ER71, Scl, and Alk8 signaling controls endothelial and myeloid cell formation. Blood 2008; 111: 4500-4510.
19. De Val S, Anderson JP, Heidt AB, Khiem D, Xu SM, Black BL. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. Dev Biol 2004; 275: 424-434.
20. Ferdous A, Caprioli A, Iacovino M, et al. Nkx2-5 transactivates the Ets-related protein 71 gene and specifies an endothelial/ endocardial fate in the developing embryo. Proc Natl Acad Sci USA 2009; 106: 814-819.
21. Barton K, Muthusamy N, Fischer C, et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 1998; 9: 555-563.
22. Loughran SJ, Kruse EA, Hacking DF, et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat Immunol 2008; 9: 810-819.
23. Bories JC, Willerford DM, Grévin D, et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 1995; 377: 635-638.
24. Spyropoulos DD, Pharr PN, Lavenburg KR, et al. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 2000; 20: 5643-5652.
25. Hart A, Melet F, Grossfeld P, et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000; 13: 167-177.
26. Kruse EA, Loughran SJ, Baldwin TM, et al. Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage. Proc Natl Acad Sci USA 2009; 106: 13814-13819.
27. Wei G, Srinivasan R, Cantemir-Stone CZ, et al. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 2009; 114: 1123-1130.
28. Lettice LA, Hill RE. Preaxial polydactyly: a model for defective long-range regulation in congenital abnormalities. Curr Opin Genet Dev 2005; 15: 294-300.
29. Sementchenko VI, Watson DK. Ets target genes: past, present and future. Oncogene 2000; 19: 6533-6548.
30. Man A, Young L, Tynan J, et al. Ets2-dependent stromal regulation of mouse mammary tumors. Mol Cell Biol 2003; 23: 8614-8625.
31. Tynan JA, Wen F, Muller WJ, Oshima RG. Ets2-dependent microenvironmental support of mouse mammary tumors. Oncogene 2005; 24: 6870-6876.
32. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
33. Bhowmick NA, Chytil A, Plieth D, et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-851.
34. Trimboli AJ, Cantemir-Stone CZ, Li F, et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461: 1084-1091.
35. Overall CM, Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006; 6: 227-239.
36. Bergers G, Brekken R, McMahon G, et al. Matrix metallo- proteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-744.
37. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol 2009; 9: 259-270.
38. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-252.
39. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263-266.
40. Sica A, Larghi P, Mancino A, et al. Macrophage polarization in tumour progression. Semin Cancer Biol 2008; 18: 349-355.
41. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimu-lating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193: 727-740.
42. Fowles LF, Martin ML, Nelsen L, et al. Persistent activation of mitogen-activated protein kinases p42 and p44 and Ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol Cell Biol 1998; 18: 5148-5156.
43. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265-277.
44. Zabuawala T, Taffany DA, Sharma SM, et al. An Ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis. Cancer Res 2010; 70: 1323-1333.
45. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127: 679-695.
46. Borowsky AD, Namba R, Young LJ, et al. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis 2005; 22: 47-59.
47. Sussan TE, Yang A, Li F, Ostrowski MC, Reeves RH. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature 2008; 451: 73-75.